(S (NP-SBJ (NN Interleukin-4)) (VP (VBZ inhibits) (NP (NP (DT the) (NP-COOD (NP (NP (JJ lipopolysaccharide-induced) (NN expression)) (PP (IN of) (NP (NP-COOD (NP (NN c-jun)) (CC and) (NP (NN c-fos))) (NN messenger) (NN RNA)))) (CC and) (NP (NN activator) (NN protein-1) (NN binding) (NN activity)))) (PP (IN in) (NP (JJ human) (NNS monocytes))))) (. .))
(S (NP-SBJ (PRP We)) (VP (VBD studied) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NP (NN interleukin-4)) (PRN (-LRB- -LRB-) (NP (NN IL-4)) (-RRB- -RRB-)))) (PP (IN on) (NP (NP (DT the) (NP (NP (NN lipopolysaccharide)) (PRN (-LRB- -LRB-) (NP (NN LPS)) (-RRB- -RRB-))) (NN induction)) (PP (IN of) (NP (CD two) (JJ immediate) (JJ early) (NNS genes) (NP-COOD (NP (NN c-fos)) (CC and) (NP (NN c-jun))))))))) (. .))
(S (NP-SBJ (DT These) (NNS genes)) (VP (VBP encode) (NP (NP (NNS proteins)) (SBAR (WHNP-80 (WDT that)) (S (NP-SBJ (-NONE- *T*-80)) (VP (VBP form) (NP (NP (NP (DT the) (JJ dimeric) (NN complex) (NN activator) (NN protein-1)) (PRN (-LRB- -LRB-) (NP (NN AP-1)) (-RRB- -RRB-))) (, ,) (SBAR (WHNP-81 (WDT which)) (S (NP-SBJ (-NONE- *T*-81)) (VP (VBZ is) (ADJP-PRD (JJ active)) (PP (IN as) (NP (DT a) (JJ transcriptional) (NN factor)))))))))))) (. .))
(S (NP-SBJ (NP (JJ Maximal) (NN accumulation)) (PP (IN of) (NP (NP-COOD (CC either) (NP (NN c-fos)) (CC and) (NP (NN c-jun))) (NP (NP (NN messenger) (NN RNA)) (PRN (-LRB- -LRB-) (NP (NN mRNA)) (-RRB- -RRB-)))))) (VP (VBD occurred) (PP-TMP (NP (CD 30) (NNS minutes)) (IN after) (NP (NN LPS) (NN addition)))) (. .))
(S (SBAR-TMP (WHADVP-82 (WRB When)) (S (NP-SBJ-83 (NNS cells)) (VP (VBD were) (VP (VBN treated) (NP (-NONE- *-83)) (PP (IN with) (NP (NN IL-4))) (PP-TMP (IN for) (NP (CD 5) (NNS hours))) (PP-TMP (IN before) (NP (NN LPS) (NN activation))) (ADVP (-NONE- *T*-82)))))) (, ,) (NP-SBJ-84 (NP-COOD (CC both) (NP (DT the) (NN c-fos) (NP (-NONE- *RNR*-85))) (CC and) (NP (DT the) (NN c-jun) (NP (-NONE- *RNR*-85)))) (NP-85 (NN mRNA) (NN expression))) (VP (VBD was) (VP (VBN decreased) (NP (-NONE- *-84)))) (. .))
(S (NP-SBJ-86 (NP (DT The) (NN inhibition)) (PP (IN of) (NP (NP-COOD (NP (NN c-fos)) (CC and) (NP (NN c-jun))) (NN expression))) (PP (IN by) (NP (NN IL-4))) (PP (IN in) (NP (JJ LPS-treated) (NNS cells)))) (VP (VBD was) (VP (VBN shown) (S (NP-SBJ (-NONE- *-86)) (VP (TO to) (VP (VB be) (PP-PRD (JJ due) (TO to) (NP (NP (DT a) (JJR lower) (NN transcription) (NN rate)) (PP (IN of) (NP (DT the) (NP-COOD (NP (NN c-fos)) (CC and) (NP (NN c-jun))) (NNS genes)))))))))) (. .))
(S (NP-SBJ (NN IL-4)) (VP (VBD did) (RB not) (VP (VB affect) (NP (NP (DT the) (NN stability)) (PP (IN of) (NP (DT the) (NP-COOD (NP (NN c-fos)) (CC and) (NP (NN c-jun))) (NNS transcripts)))))) (. .))
(S (ADVP-TMP (RB Finally)) (, ,) (S (NP-SBJ (-NONE- *)) (VP (VBG using) (NP (JJ electrophoretic) (NN mobility) (NN shift) (NNS assays)))) (, ,) (NP-SBJ-101 (NN evidence) (SBAR (-NONE- *ICH*-100))) (VP (VBD was) (VP (VBN obtained) (NP (-NONE- *-101)) (SBAR-100 (IN that) (S (NP-SBJ (NN IL-4)) (VP (VBZ inhibits) (NP (NP (JJ LPS-induced) (NN expression)) (PP (IN of) (NP (NN AP-1) (NN protein))))))))) (. .))
(S (NP-SBJ (DT These) (NNS data)) (VP (VBP indicate) (SBAR (IN that) (S (NP-SBJ (NN IL-4)) (VP (VBZ suppresses) (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (NN transcription) (NNS factors))) (PP (IN in) (NP (JJ human) (VBN activated) (NNS monocytes)))))))) (. .))
